Silicon Valley Capital Partners Regeneron Pharmaceuticals, Inc. Transaction History
Silicon Valley Capital Partners
- $894 Million
- Q4 2024
A detailed history of Silicon Valley Capital Partners transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Silicon Valley Capital Partners holds 4 shares of REGN stock, worth $2,691. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4Holding current value
$2,691% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,500Shares Held
83MCall Options Held
1.22MPut Options Held
1.5M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.27 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.68 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.04 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.3 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$2.89 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $72.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...